Literature DB >> 20868402

Medical and surgical approaches to vulvar intraepithelial neoplasia.

Kimberly W Lai1, Mary Gail Mercurio.   

Abstract

Vulvar intraepithelial neoplasia (VIN) is a precursor to invasive vulvar carcinoma. The two major types of VIN, usual and differentiated, differ in epidemiology, pathogenesis, clinical manifestations, pathology, and malignant potential. Usual VIN commonly occurs in younger women. It is associated with human papillomavirus and tends to have multifocal and multicentric involvement. Differentiated VIN is frequently associated with benign vulvar dermatoses such as lichen sclerosus and lichen simplex chronicus. It occurs in older women and typically is unifocal and unicentric. Clinicians must have a high suspicion for VIN, which is diagnosed by biopsy. Surgical excision has been the standard treatment in order to prevent progression to invasive disease. The objectives of treatment have expanded to include preservation of normal vulvar function and anatomy. Therefore, management options are being investigated, including topical therapy, laser excision and vaporization, and photodynamic therapy. All can be effective in both eliminating disease and maintaining relatively normal-appearing and functioning anatomy.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20868402     DOI: 10.1111/j.1529-8019.2010.01351.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  2 in total

1.  The re-infection rate of high-risk HPV and the recurrence rate of vulvar intraepithelial neoplasia (VIN) usual type after surgical treatment.

Authors:  Antonio Frega; Francesco Sopracordevole; Paolo Scirpa; Alberto Biamonti; Laura Lorenzon; Simona Scarani; Luana De Sanctis; Arianna Pacchiarotti; Massimo Moscarini; Deborah French
Journal:  Med Sci Monit       Date:  2011-09

Review 2.  Use of topical imiquimod in the treatment of VIN: a case report and review of the literature.

Authors:  Chelsea Grimes; Cheri Cunningham; Michael Lee; Andrea Murina
Journal:  Int J Womens Dermatol       Date:  2016-03-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.